The 24.8% relative risk reduction in prostate cancer seen in the finasteride arm prompted the early termination of the study on February 21, 2003, 15 months before its anticipated completion.

The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...

D'Amico AV and Roehrborn CG (2007) Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Lancet Oncol ...

About prostate enlargement, a condition that affects only men and becomes more common with age, Dr. Amit Gala provides a comprehensive guide to managing prostate health.

Finasteride was initially approved by the Food and Drug Administration (FDA) to treat benign prostatic hyperplasia (BPH), which is an enlarged prostate gland. By lowering DHT levels, finasteride ...

Among patients with prostate cancer, a high omega-3, low-omega-6 diet with fish oil led to a Ki-67 index decrease.

Finasteride has two FDA-approved usages. One is to help treat benign prostatic hyperplasia (aka enlarged prostate). Second, finasteride, a 5-alpha-reductase, helps promote hair growth by blocking ...

Molecular studies of the PCPT...should allow personalized prevention of prostate cancer with finasteride Uniquely, the PCPT was designed to ascertain its primary endpoint (detection of prostate ...